Local Institution - 125

Toronto, Ontario M5G 2M9

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myeloid, Acute

Studies at this site

• A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy — Running, not enrolling